97
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Antibiotic resistance - Meet the challenge

      Published
      conference-abstract
      1
      REPO4EU
      RExPO24
      3-5 July 2024
      Antimicrobial resistance, antibiotic development, alternative approaches, drug repurposing
      Bookmark

            Abstract

            Antimicrobial resistance (AMR) is one of the biggest threats to human health and lives. Beside an expected increase of death cases caused by resistant bacterial infections to 10 mio worldwide, AMR will compromise the achievements of modern medicine, impact world economy and social security.

            In my presentation, I will summarize the need for point-of-care diagnostics, alternative approaches to treat bacterial infections. Furthermore, the overall challenge of appropriate antibiotic reimbursement, which is a major obstacle in the field, will be discussed.

            For successful drug repurposing in the field of AMR, specific requirements in terms of physico-chemical properties and toxicity of compounds need to be met. Strategies to solve these issues will be discussed.

            Content

            Author and article information

            Conference
            REPO4EU
            22 April 2024
            Affiliations
            [1 ] echnical University of Munich, TUM School of Medicine and Health, Department of Preclinical Medicine, Chair of Medical Microbiology, Immunology and Hygiene, Munich, Germany ( https://ror.org/02kkvpp62)
            Article
            10.58647/REXPO.24002
            2d0cb407-ef0b-4638-8fb5-a0aff56c3dd9
            The Author

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            RExPO24
            3
            Munich, Germany
            3-5 July 2024
            History
            Product

            REPO4EU

            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Medicine,Pharmacology & Pharmaceutical medicine
            Antimicrobial resistance,antibiotic development,alternative approaches,drug repurposing

            Comments

            Comment on this article